Synergistic interactions between DMAG and mitogen- activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate
Tri K. Nguyen, Mohamed Rahmani, Ning Gao, Lora Kramer, Amie S. Corbin, Brian J. Druker, Paul Dent, Steven Grant
Dive into the research topics of 'Synergistic interactions between DMAG and mitogen- activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate'. Together they form a unique fingerprint.